首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >PNAS Plus: Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response
【2h】

PNAS Plus: Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response

机译:PNAS Plus:稳定的单次注射灭活脊髓灰质炎疫苗引起强烈的中和免疫反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vaccination in the developing world is hampered by limited patient access, which prevents individuals from receiving the multiple injections necessary for protective immunity. Here, we developed an injectable microparticle formulation of the inactivated polio vaccine (IPV) that releases multiple pulses of stable antigen over time. To accomplish this, we established an IPV stabilization strategy using cationic polymers for pH modulation to enhance traditional small-molecule–based stabilization methods. We investigated the mechanism of this strategy and showed that it was broadly applicable to all three antigens in IPV. Our lead formulations released two bursts of IPV 1 month apart, mimicking a typical vaccination schedule in the developing world. One injection of the controlled-release formulations elicited a similar or better neutralizing response in rats, considered the correlate of protection in humans, than multiple injections of liquid vaccine. This single-administration vaccine strategy has the potential to improve vaccine coverage in the developing world.
机译:发展中国家的疫苗接种受到患者的有限访问的阻碍,这阻止了个人接受保护性免疫所必需的多次注射。在这里,我们开发了灭活的脊髓灰质炎疫苗(IPV)的可注射微粒制剂,该制剂随时间释放多个稳定抗原脉冲。为了实现这一目标,我们建立了使用阳离子聚合物进行pH调节的IPV稳定策略,以增强传统的基于小分子的稳定方法。我们研究了该策略的机制,并表明它广泛适用于IPV中的所有三种抗原。我们的先导配方相隔1个月释放了两次IPV爆发,模仿了发展中国家的典型疫苗接种时间表。与多次注射液体疫苗相比,一次注射的控释制剂在大鼠中引起相似或更好的中和反应,这被认为是与人类保护的相关性。这种单剂疫苗策略具有改善发展中国家疫苗覆盖率的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号